Synergy Asset Management LLC Has $15.65 Million Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Synergy Asset Management LLC lifted its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 856.5% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 31,631 shares of the healthcare conglomerate’s stock after acquiring an additional 28,324 shares during the period. UnitedHealth Group makes up 2.7% of Synergy Asset Management LLC’s holdings, making the stock its 11th biggest holding. Synergy Asset Management LLC’s holdings in UnitedHealth Group were worth $15,648,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the stock. Richelieu Gestion SA purchased a new position in shares of UnitedHealth Group in the 4th quarter worth about $26,000. CGC Financial Services LLC raised its stake in shares of UnitedHealth Group by 1,000.0% in the fourth quarter. CGC Financial Services LLC now owns 55 shares of the healthcare conglomerate’s stock valued at $29,000 after buying an additional 50 shares during the period. True Wealth Design LLC bought a new position in shares of UnitedHealth Group in the fourth quarter worth $31,000. LFA Lugano Financial Advisors SA lifted its holdings in shares of UnitedHealth Group by 148.1% during the 4th quarter. LFA Lugano Financial Advisors SA now owns 67 shares of the healthcare conglomerate’s stock worth $35,000 after acquiring an additional 40 shares during the last quarter. Finally, Transcendent Capital Group LLC bought a new position in UnitedHealth Group in the fourth quarter valued at $40,000. 87.86% of the stock is owned by institutional investors.

UnitedHealth Group Stock Performance

NYSE:UNH traded up $3.06 on Tuesday, hitting $497.71. The stock had a trading volume of 1,581,311 shares, compared to its average volume of 4,279,616. The business’s 50-day simple moving average is $498.34 and its two-hundred day simple moving average is $501.63. UnitedHealth Group Incorporated has a 52-week low of $436.38 and a 52-week high of $554.70. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 0.69. The stock has a market cap of $458.09 billion, a price-to-earnings ratio of 30.22, a price-to-earnings-growth ratio of 1.48 and a beta of 0.60.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.63 by $0.28. UnitedHealth Group had a net margin of 4.05% and a return on equity of 26.50%. The company had revenue of $99.80 billion during the quarter, compared to analyst estimates of $99.23 billion. During the same period in the prior year, the firm posted $6.26 EPS. The firm’s quarterly revenue was up 8.6% compared to the same quarter last year. As a group, research analysts predict that UnitedHealth Group Incorporated will post 27.55 earnings per share for the current year.

UnitedHealth Group Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, June 25th. Investors of record on Monday, June 17th were given a $2.10 dividend. This is a positive change from UnitedHealth Group’s previous quarterly dividend of $1.88. This represents a $8.40 dividend on an annualized basis and a yield of 1.69%. The ex-dividend date was Monday, June 17th. UnitedHealth Group’s dividend payout ratio is 51.34%.

Analyst Ratings Changes

Several equities analysts recently issued reports on the company. Erste Group Bank restated a “hold” rating on shares of UnitedHealth Group in a research report on Wednesday, March 13th. Truist Financial reiterated a “buy” rating and set a $600.00 target price on shares of UnitedHealth Group in a report on Wednesday, April 17th. Deutsche Bank Aktiengesellschaft increased their price objective on UnitedHealth Group from $545.00 to $562.00 and gave the stock a “buy” rating in a report on Friday, April 19th. Robert W. Baird started coverage on shares of UnitedHealth Group in a report on Thursday, May 30th. They issued an “outperform” rating and a $597.00 price target on the stock. Finally, Morgan Stanley cut their target price on shares of UnitedHealth Group from $618.00 to $584.00 and set an “overweight” rating on the stock in a research note on Friday, April 5th. Three research analysts have rated the stock with a hold rating, seventeen have assigned a buy rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $579.74.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.